https://news.augustaheadlines.com/story/411517/veteranowned-roofing-company-is-empowering-the-north-carolina-community-through-their-positive-practices.html 2023-03-13T22:30:05+00:00 daily 1.0 https://news.augustaheadlines.com/story/411515/meet-david-ala-aggayu-a-doctor-in-anthropology-high-priest-and-a-writer-on-african-and-cuban-religion.html 2023-03-13T22:24:18+00:00 daily 1.0 https://news.augustaheadlines.com/story/411603/myelofibrosis-emerging-and-marketed-drugs-assessment-2023-updates-clinical-trials-latest-fda-ema-and-pmda-approvals-treatment-outlook-competitive-landscape-and-key-companies.html 2023-03-13T22:24:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/411600/betathalassemia-bthal-market-is-predicted-to-exhibit-remarkable-growth-during-the-forecast-period-20222032-analyzes-delveinsight-key-companies-phoenicia-edigene-imara-agios-ionis.html 2023-03-13T22:18:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/411513/imrockstar-to-launch-a-singing-contest-and-web3-artist-community-that-gives-aspiring-musicians-the-opportunity-to-bring-their-dreams-to-life-on-the-virtual-stage.html 2023-03-13T22:18:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/411599/severe-hypertriglyceridemia-emerging-and-marketed-drugs-assessment-2023-updates-clinical-trials-latest-fda-ema-and-pmda-approvals-treatment-outlook-competitive-landscape-and-key-companies.html 2023-03-13T22:16:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/411598/type-1-diabetes-emerging-and-marketed-drugs-assessment-2023-updates-clinical-trials-latest-fda-ema-and-pmda-approvals-treatment-outlook-competitive-landscape-and-key-companies.html 2023-03-13T22:14:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/411596/essential-tremor-emerging-and-marketed-drugs-assessment-2023-updates-clinical-trials-latest-fda-ema-and-pmda-approvals-treatment-outlook-competitive-landscape-and-key-companies.html 2023-03-13T22:08:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/411594/postsurgical-pain-market-to-register-incremental-growth-during-the-forecast-period-202232-delveinsight-key-companies-acelrx-trevena-vivozon-teikoku-pharma-nevakar-oculis-painreform.html 2023-03-13T22:02:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/411592/inflammatory-bowel-disease-market-to-witness-upsurge-in-growth-during-the-forecast-period-20222032-examine-delveinsight-key-companies-janssen-abbvie-eli-lilly-gilead-galapagos-astrazeneca.html 2023-03-13T21:56:02+00:00 daily 1.0